Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.84 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | HRH1 | P35367 | 2/20 | 0.37 |
| ▸ | CX3CR1 | P49238 | 1/20 | 0.37 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15140860 | 1.00 | CHRM2 (0.84) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL812986 | 0.91 | CHRM2 (1.00) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL29366015 | 0.91 | CHRM2 (1.00) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL15148766 | 0.91 | CHRM2 (1.00) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL1808421 | 0.91 | CHRM2 (1.00) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL121127 | 0.91 | CHRM2 (1.00) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL3688110 | 0.90 | CHRM2 (0.98) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL2474276 | 0.90 | CHRM2 (0.98) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL2474910 | 0.89 | CHRM2 (0.96) | CHRM2CHRM1ALOX15ADRB2ADRA1A | |
| Fesoterodine SCHEMBL2474905 | 0.89 | CHRM2 (0.96) | CHRM2CHRM1ALOX15ADRB2ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012678-B2 | Processes for the preparation of fesoterodine | CADILA HEALTHCARE LIMITED (IN) | 2015-04-21 | — | — | US | disclosed |
| US-9012678-B2 | Processes for the preparation of fesoterodine | CADILA HEALTHCARE LIMITED (IN) | 2015-04-21 | — | — | US | disclosed |
| US-9012678-B2 | Processes for the preparation of fesoterodine | CADILA HEALTHCARE LIMITED (IN) | 2015-04-21 | — | — | US | disclosed |
| US-20130197260-A1 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2013-08-01 | — | — | US | disclosed |
| US-20130197260-A1 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2013-08-01 | — | — | US | disclosed |
| US-20130197260-A1 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2013-08-01 | — | — | US | disclosed |
| WO-2012025941-A2 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130197260-A1 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | QDPR, FES, SULT1A1 | CHRM2 211/4885CHRM1 165/4885ALOX15 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.